Correction to: Novel immunotherapeutics against LGR5 to target multiple cancer types (EMBO Molecular Medicine, (2024), 16, 9, (2233-2261), 10.1038/s44321-024-00121-2)

Hung Chang Chen; Nico Mueller; Katherine Stott; Chrysa Kapeni; Eilidh Rivers; Carolin M. Sauer; Flavio Beke; Stephen J. Walsh; Nicola Ashman; Louise O’Brien; Amir Rafati Fard; Arman Ghodsinia; Changtai Li; Fadwa Joud; Olivier Giger; Inti Zlobec; Ioana Olan; Sarah J. Aitken; Matthew Hoare; Richard Mair; Eva Serrao; James D. Brenton; Alicia Garcia-Gimenez; Simon E. Richardson; Brian Huntly; David R. Spring; Mikkel Ole Skjoedt; Karsten Skjødt; Marc de la Roche; Maike de la Roche

doi:10.1038/s44321-024-00139-6

Correction to: Novel immunotherapeutics against LGR5 to target multiple cancer types (EMBO Molecular Medicine, (2024), 16, 9, (2233-2261), 10.1038/s44321-024-00121-2)

Hung Chang Chen
, Nico Mueller
, Katherine Stott
, Chrysa Kapeni
, Eilidh Rivers
, Carolin M. Sauer
, Flavio Beke
, Stephen J. Walsh
, Nicola Ashman
, Louise O’Brien
, Amir Rafati Fard
, Arman Ghodsinia
, Changtai Li
, Fadwa Joud
, Olivier Giger
, Inti Zlobec
, Ioana Olan
, Sarah J. Aitken
, Matthew Hoare
, Richard Mair

Eva Serrao, James D. Brenton, Alicia Garcia-Gimenez, Simon E. Richardson, Brian Huntly, David R. Spring, Mikkel Ole Skjoedt, Karsten Skjødt, Marc de la Roche^*, Maike de la Roche^*

^*Corresponding author for this work

Research output: Contribution to journal › Correction

2 Citations (Scopus)

Abstract

The 12th author’s name is corrected. The 12th author’s name is corrected from: Arman Godsinia To: (Changes in bold). Arman Ghodsinia The original article has been corrected.

Original language	English
Pages (from-to)	3026
Number of pages	1
Journal	EMBO Molecular Medicine
Volume	16
Issue number	11
DOIs	https://doi.org/10.1038/s44321-024-00139-6
Publication status	Published - 11 Nov 2024
Externally published	Yes

Access to Document

10.1038/s44321-024-00139-6

Cite this

Chen, H. C., Mueller, N., Stott, K., Kapeni, C., Rivers, E., Sauer, C. M., Beke, F., Walsh, S. J., Ashman, N., O’Brien, L., Rafati Fard, A., Ghodsinia, A., Li, C., Joud, F., Giger, O., Zlobec, I., Olan, I., Aitken, S. J., Hoare, M., ... de la Roche, M. (2024). Correction to: Novel immunotherapeutics against LGR5 to target multiple cancer types (EMBO Molecular Medicine, (2024), 16, 9, (2233-2261), 10.1038/s44321-024-00121-2). EMBO Molecular Medicine, 16(11), 3026. https://doi.org/10.1038/s44321-024-00139-6

@article{3c6969aa313b4536a7f26ab209392d51,

title = "Correction to: Novel immunotherapeutics against LGR5 to target multiple cancer types (EMBO Molecular Medicine, (2024), 16, 9, (2233-2261), 10.1038/s44321-024-00121-2)",

abstract = "The 12th author{\textquoteright}s name is corrected. The 12th author{\textquoteright}s name is corrected from: Arman Godsinia To: (Changes in bold). Arman Ghodsinia The original article has been corrected.",

author = "Chen, \{Hung Chang\} and Nico Mueller and Katherine Stott and Chrysa Kapeni and Eilidh Rivers and Sauer, \{Carolin M.\} and Flavio Beke and Walsh, \{Stephen J.\} and Nicola Ashman and Louise O{\textquoteright}Brien and \{Rafati Fard\}, Amir and Arman Ghodsinia and Changtai Li and Fadwa Joud and Olivier Giger and Inti Zlobec and Ioana Olan and Aitken, \{Sarah J.\} and Matthew Hoare and Richard Mair and Eva Serrao and Brenton, \{James D.\} and Alicia Garcia-Gimenez and Richardson, \{Simon E.\} and Brian Huntly and Spring, \{David R.\} and Skjoedt, \{Mikkel Ole\} and Karsten Skj{\o}dt and \{de la Roche\}, Marc and \{de la Roche\}, Maike",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = nov,

day = "11",

doi = "10.1038/s44321-024-00139-6",

language = "English",

volume = "16",

pages = "3026",

journal = "EMBO Molecular Medicine",

issn = "1757-4676",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "11",

}

Chen, HC, Mueller, N, Stott, K, Kapeni, C, Rivers, E, Sauer, CM, Beke, F, Walsh, SJ, Ashman, N, O’Brien, L, Rafati Fard, A, Ghodsinia, A, Li, C, Joud, F, Giger, O, Zlobec, I, Olan, I, Aitken, SJ, Hoare, M, Mair, R, Serrao, E, Brenton, JD, Garcia-Gimenez, A, Richardson, SE, Huntly, B, Spring, DR, Skjoedt, MO, Skjødt, K, de la Roche, M & de la Roche, M 2024, 'Correction to: Novel immunotherapeutics against LGR5 to target multiple cancer types (EMBO Molecular Medicine, (2024), 16, 9, (2233-2261), 10.1038/s44321-024-00121-2)', EMBO Molecular Medicine, vol. 16, no. 11, pp. 3026. https://doi.org/10.1038/s44321-024-00139-6

TY - JOUR

T1 - Correction to

T2 - Novel immunotherapeutics against LGR5 to target multiple cancer types (EMBO Molecular Medicine, (2024), 16, 9, (2233-2261), 10.1038/s44321-024-00121-2)

AU - Chen, Hung Chang

AU - Mueller, Nico

AU - Stott, Katherine

AU - Kapeni, Chrysa

AU - Rivers, Eilidh

AU - Sauer, Carolin M.

AU - Beke, Flavio

AU - Walsh, Stephen J.

AU - Ashman, Nicola

AU - O’Brien, Louise

AU - Rafati Fard, Amir

AU - Ghodsinia, Arman

AU - Li, Changtai

AU - Joud, Fadwa

AU - Giger, Olivier

AU - Zlobec, Inti

AU - Olan, Ioana

AU - Aitken, Sarah J.

AU - Hoare, Matthew

AU - Mair, Richard

AU - Serrao, Eva

AU - Brenton, James D.

AU - Garcia-Gimenez, Alicia

AU - Richardson, Simon E.

AU - Huntly, Brian

AU - Spring, David R.

AU - Skjoedt, Mikkel Ole

AU - Skjødt, Karsten

AU - de la Roche, Marc

AU - de la Roche, Maike

PY - 2024/11/11

Y1 - 2024/11/11

N2 - The 12th author’s name is corrected. The 12th author’s name is corrected from: Arman Godsinia To: (Changes in bold). Arman Ghodsinia The original article has been corrected.

AB - The 12th author’s name is corrected. The 12th author’s name is corrected from: Arman Godsinia To: (Changes in bold). Arman Ghodsinia The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85205068723

U2 - 10.1038/s44321-024-00139-6

DO - 10.1038/s44321-024-00139-6

M3 - Correction

C2 - 39322863

AN - SCOPUS:85205068723

SN - 1757-4676

VL - 16

SP - 3026

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

IS - 11

ER -

Correction to: Novel immunotherapeutics against LGR5 to target multiple cancer types (EMBO Molecular Medicine, (2024), 16, 9, (2233-2261), 10.1038/s44321-024-00121-2)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this